Skip to contentC
Chemed Corp
C
CHEChemed Corp Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$65.58M$65.58Mderived+20.7% vs Q4 2018 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived$77,452,000+14.9%
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Operating Cash Flowderived$63,604,000+12.5% Free Cash Flowderived$50,335,000+25.2% ended Dec 31, 2019 · filed Feb 26, 2020 · 57 d after period end